ArticleDrug delivery2026

Dual-ligand-modified cantharidin nanoparticles for the treatment of hepatocellular carcinoma via the inhibition of Ephb4.

Wanting Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.